JDD

Understanding and Changing Patient Behavior and Minimizing Risk of UV Damage – A JDD Dermatology Podcast Recap
117551175511755UV damageWe all discuss sun protection with our patients.  At this point, our recommendations are predictable – “avoidance, protective clothing, SPF 30+, broad-spectrum, water-resistant, and reapplication.” But how can we effectively change patient behavior? Important note – this discussion has wide arching correlations to all areas of human behavior, medicine, and dermatology that spans more th …
UV damage
July 2021 JDD Issue | Special Topic: Skin of Color
135621356213562JDD Skin of Color IssueWith a special focus on patients with skin of color, the July issue of the Journal of Drugs in Dermatology is packed with outstanding articles, features, and case reports on topics ranging from OTC therapies for hair grow and choosing the right sunscreen in communities of color, to evaluation of a skin of color curriculum for dermatology residents and PLLA for correction of nasolabial folds. Stra …
JDD Skin of Color Issue
Skin of Color Update 2021: Bigger & Better Than Ever!
135071350713507Skin of Color UpdateSkin of Color Update, the largest medical education event focused on the dermatologic treatment of patients with skin of color, is expanding in 2021 with an additional half day of programming and pre-conference symposium. The event will be held virtually September 10-12 with the symposium on August 3. “The expanded program will allow us to address even more topics and provide more in-depth co …
Skin of Color Update
Special Focus on Acne and Rosacea
133171331713317Acne and RosaceaThe June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist …
Acne and Rosacea
Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline
131421314213142Periorificial DermatitisBroad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic resistance and gut dysbiosis associated with broad spectrum tetracyclines emphasizes the importance and responsibility of antibiotic stewardship. Narrow spectrum antibiotics have become increasingly impo …
Periorificial Dermatitis